I. Taylor

I. Taylor, M. Friedlander, E. Musgrove, 1983, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

DNA flow cytometry of paraffin-embedded tissue.

I. Taylor, D. Hedley, M. Friedlander, 1984, Cytometry.

Influence of Cellular DMA Content on Survival in Advanced Ovarian Cancer

M. Tattersall, I. Taylor, D. Hedley, 2006 .

ELIMINATION OF GLYCERYL TRINITRATE: EFFECTS OF SEX, AGE, SPECIES AND ROUTE OF ADMINISTRATION

C. Ioannides, D. Parke, I. Taylor, 1982, British journal of pharmacology.

Altered cell cycle progression and aberrant mitosis in adenovirus‐infected rodent cells

I. Taylor, A. Braithwaite, A. Bellett, 1982, Journal of cellular physiology.

Flow cytometric analysis of DNA content of mouse liver cells following in vivo infection by human adenovirus type 5.

I. Taylor, J. Murray, M. Berger, 1981, The Journal of general virology.

Selective toxicity of a new lipophilic antifolate, BW301U, for methotrexate-resistant cells with reduced drug uptake.

I. Taylor, M. Friedlander, M. Tattersall, 1985, Cancer research.

G1-phase arrest of cultured human leukemic T-cells induced by deoxyadenosine.

I. Taylor, R. Kefford, R. Fox, 1981, Cancer research.

Cloning and Expression of Cytosolic Phospholipase A2 (cPLA2) and a Naturally Occurring Variant

I. Taylor, G. A. Ritchie, D. Campbell, 1996 .

Cloning and expression of cystolic phospholipase A2 (cPLA2) and a naturally occurring variant. Phosphorylation of Ser505 of recombinant cPLA2 by p42 mitogen-activated protein kinase results in an increase in specific activity.

I. Taylor, R. Gordon, G. A. Ritchie, 1996, European journal of biochemistry.

Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.

I W Taylor, I. Taylor, D. Hedley, 1983, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells.

I W Taylor, I. Taylor, R. Sutherland, 1983, Cancer research.

Ovarian tumour xenografts in the study of the biology of human epithelial ovarian cancer.

I. Taylor, M. Friedlander, M. Tattersall, 1985, British Journal of Cancer.

The influence of age on the DNA ploidy levels of breast tumours.

I. Taylor, D. Hedley, M. Friedlander, 1983, European journal of cancer & clinical oncology.

Flow cytometric analysis of adenosine analogue lymphocytotoxicity.

I. Taylor, R. Kefford, R. Fox, 1983, Cancer research.

Measurement of cellular DNA content as an adjunct to diagnostic cytology in malignant effusions.

I. Taylor, D. Hedley, C. Rugg, 1984, European journal of cancer & clinical oncology.

Effects of tamoxifen on cell cycle progression of synchronous MCF-7 human mammary carcinoma cells.

I. Taylor, R. Sutherland, M. Green, 1983, Cancer research.

Changes in sensitivity to radiation and ICRF 159 during the life of monolayer cultures of EMT6 tumour line.

I. Taylor, N. Bleehen, 1977, British Journal of Cancer.

Biochemical and cell cycle perturbations in methotrexate-treated cells.

I. Taylor, M. Tattersall, P. Slowiaczek, 1982, Molecular pharmacology.

An evaluation of DNA fluorochromes, staining techniques, and analysis for flow cytometry. I. Unperturbed cell populations.

I. Taylor, B. Milthorpe, 1980, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

The gut wall metabolism of ethinyloestradiol and its contribution to the pre-systemic metabolism of ethinyloestradiol in humans.

A. Breckenridge, I. Taylor, D. Back, 1982, British journal of clinical pharmacology.

First-in-human phase I study of ARV-110, an androgen receptor (AR) PROTAC degrader in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) following enzalutamide (ENZ) and/or abiraterone (ABI).

I. Taylor, H. Burris, D. Petrylak, 2020 .

Refolding, purification, and characterization of a loop deletion mutant of human Bcl-2 from bacterial inclusion bodies.

I. Taylor, A. Breeze, M Anderson, 1999, Protein expression and purification.

Functional non-synonymous single nucleotide polymorphisms from the TGF-β protein interaction network

I. Taylor, J. Wrana, H. Ozçelik, 2006 .

Clinical and biological significance of aneuploidy in human tumours.

I. Taylor, D. Hedley, M. Friedlander, 1984, Journal of clinical pathology.

Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan.

I. Taylor, R. Pauptit, C. Minshull, 1999, Biochemistry.

Abstract P5-04-18: ARV-471, an oral estrogen receptor PROTAC degrader for breast cancer

J. Flanagan, I. Taylor, C. Crews, 2019, Poster Session Abstracts.

Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients.

I. Taylor, D. Hedley, C. Rugg, 1984, Cancer research.

Cell cycle regulation by environmental pH

I W Taylor, I. Taylor, P J Hodson, 1984, Journal of cellular physiology.

Influence of cellular DNA content on survival in advanced ovarian cancer.

I. Taylor, D. Hedley, M. Friedlander, 1984, Cancer research.

Methotrexate cytotoxicity in cultured human leukemic cells studied by flow cytometry.

I. Taylor, M. Tattersall, 1981, Cancer research.

HIV-1 capsid is involved in post-nuclear entry steps

G. Nicastro, I. Taylor, J. Luban, 2016, Retrovirology.

Estimation of nonproliferating cells in the neural retina of embryonic chicks by flow cytometry.

I W Taylor, I. Taylor, V. Morris, 1985, Cytometry.

Alginate Biosynthesis by Pseudomonas mendocina

I. Taylor, A. Hacking, J. Govan, 1983 .

Pharmacokinetics and metabolism of organic nitrate vasodilators

I. Taylor, R. Bonn, T. Taylor, 1987 .

Tumour ploidy, response and survival in patients receiving endocrine therapy for advanced breast cancer.

I. Taylor, D. Hedley, R. Stuart-Harris, 1985, British Journal of Cancer.

Cellular DNA content--a stable feature in epithelial ovarian cancer.

I. Taylor, M. Friedlander, M. Tattersall, 1984, British Journal of Cancer.

Identification and quantitation of tumour cells in cell suspensions: a comparison of cytology and flow cytometry.

I. Taylor, M. Tattersall, B. Milthorpe, 1981, British Journal of Cancer.

Purine modulation of methotrexate cytotoxicity in mammalian cell lines.

I. Taylor, M. Tattersall, P. Slowiaczek, 1982, Cancer research.

Study of the interaction of the medium chain mu 2 subunit of the clathrin-associated adapter protein complex 2 with cytotoxic T-lymphocyte antigen 4 and CD28.

I. Taylor, R. Pauptit, C. Minshull, 2001, The Biochemical journal.

An analysis of two refolding routes for a C-terminally truncated human collagenase-3 expressed in Escherichia coli.

I. Taylor, W. M. Abbott, R. Ernill, 2000, Protein expression and purification.

Identification of in vitro folding conditions for procathepsin S and cathepsin S using fractional factorial screens.

I. Taylor, Brian Middleton, S. Raines, 2002, Protein expression and purification.

Crystal structure of the anti-fungal target N-myristoyl transferase

J. Irwin, I. Taylor, G. Bricogne, 1998, Nature Structural Biology.

The entropic penalty of ordered water accounts for weaker binding of the antibiotic novobiocin to a resistant mutant of DNA gyrase: a thermodynamic and crystallographic study.

Walter H.J. Ward, I. Taylor, R. Pauptit, 1997, Biochemistry.

Selection of yeast able to produce ethanol from glucose at 40° C

I. Taylor, A. Hacking, C. M. Hanas, 1984, Applied Microbiology and Biotechnology.

Influence of Cellular DMA Content on Disease-free Survival of Stage II Breast Cancer Patients

I. Taylor, D. Hedley, C. Rugg, 2006 .

Determination of ximoprofen in human plasma by gas chromatography.

I. Taylor, L. Chasseaud, 1989, Journal of chromatography.

Razoxane-induced polyploidy.

I. Taylor, N. Bleehen, 1978, British Journal of Cancer.

Organic nitrate reductase: reassessment of its subcellular localization and tissue distribution and its relationship to the glutathione transferases.

C. Ioannides, D. Parke, I. Taylor, 1989, The International journal of biochemistry.

Adenovirus-induced alterations of the cell growth cycle: effects of mutations in early regions E2A and E2B

I. Taylor, A. Braithwaite, J. Murray, 1982, Journal of virology.

A comparison of high cell density fed‐batch fermentations involving both induced and non‐induced recombinant Escherichia coli under well‐mixed small‐scale and simulated poorly mixed large‐scale conditions

Alvin W Nienow, Christopher J Hewitt, C. Hewitt, 2007, Biotechnology and bioengineering.

Metabolism and pharmacokinetics of the dihydropyridine calcium antagonist, ryosidine, in man.

I. Taylor, R. Lambe, R. Bonn, 1985, Xenobiotica; the fate of foreign compounds in biological systems.

Effect of deuteration of imipramine on its pharmacokinetic properties in the rat.

C. Ioannides, D. Parke, I. Taylor, 1983, Biochemical pharmacology.

Abstract P4-04-04: Identification and development of oral estrogen receptor PROTAC degraders for breast cancer

J. Flanagan, I. Taylor, C. Crews, 2018 .

Dynamic modularity in protein interaction networks predicts breast cancer outcome

David Warde-Farley, Q. Morris, T. Pawson, 2009, Nature Biotechnology.

Furine Modulation of Methotrexate Cytotoxicity in Mammalian Cell Lines

M. Tattersall, I. Taylor, P. Slowiaczek, 2006 .

The application of multi-parameter flow cytometry to the study of recombinant Escherichia coli batch fermentation processes

Alvin W. Nienow, Christopher J. Hewitt, C. Hewitt, 2004, Journal of Industrial Microbiology and Biotechnology.